Atnaujintas knygų su minimaliais defektais pasiūlymas! Naršykite ČIA >>

Cancer Policy: Pharmaceutical Safety

-15% su kodu: ENG15
140,23 
Įprasta kaina: 164,98 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
140,23 
Įprasta kaina: 164,98 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
2025-02-28 164.9800 InStock
Nemokamas pristatymas į paštomatus per 11-15 darbo dienų užsakymams nuo 10,00 

Knygos aprašymas

Cancer Policy: Pharmaceutical Safety provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chapters provide an overview and synthesis of the latest thoughts and findings relating to drug safety in the cancer domain. Topics include natural language processing and pharmacovigilance of alternative cancer pharmaceuticals. The information presented in this volume will improve understanding of emerging strategies to identify adverse drug reactions and drug-drug interactions within the cancer setting and will highlight policies that have been instituted to improve cancer patient safety. In summary, Cancer Policy: Pharmaceutical Safety explores many of the important areas of pharmacovigilance research in oncology.

Informacija

Serija: Cancer Treatment and Research
Leidėjas: Springer Nature Switzerland
Išleidimo metai: 2019
Knygos puslapių skaičius: 136
ISBN-10: 3319438948
ISBN-13: 9783319438948
Formatas: 241 x 160 x 14 mm. Knyga kietu viršeliu
Kalba: Anglų

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „Cancer Policy: Pharmaceutical Safety“

Būtina įvertinti prekę

Goodreads reviews for „Cancer Policy: Pharmaceutical Safety“